IL6 and hydrops fetalis: Data from the Studies of Left Ventricular Dysfunction (SOLD) trial (13) outlined the increase in plasma levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in patients with HF, their concentrations rising in relation to the worsening of the HF condition.